View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by BIOVIA

Digital Lab Documentation

Free White Paper

Digital Lab Documentation


Digital Lab Documentation

Enter your details to receive the free paper:

Life Sciences organizations need to bring new high-quality therapeutics to market fast to respond to patient needs specific to different diseases and geographies. But development time and costs for new therapeutics are gigantic with an average accrual of $2.6B and 12 years from ideation to market. Reasons for the struggle include (1) the long “time to fail” in new target identification, (2) increasing global and regional regulations and
scrutiny, and (3) the major efforts required to ensure that therapeutics are safe, efficacious and compliant with specifications. Personalized Medicine and Patient Centricity add complexity to Development and Manufacturing. Testing is required to confirm therapeutic characteristics discovered during Research, to identify and optimize formulations for production and scale-up, and to release active ingredients and products.

Download the White Paper now.

Websites in our network
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy